Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)最新文献_第2页

[Bibliometric analysis of the scientific productionof asthma in Latin America].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-09-30 DOI: /10.29262/ram.v71i3.1387

Jorge Luis Gómez-Guerra, Karla Antuané Chavarri-Vargas, Rodrigo Corcuera-Ciudad

{"title":"[Bibliometric analysis of the scientific productionof asthma in Latin America].","authors":"Jorge Luis Gómez-Guerra, Karla Antuané Chavarri-Vargas, Rodrigo Corcuera-Ciudad","doi":"/10.29262/ram.v71i3.1387","DOIUrl":"/10.29262/ram.v71i3.1387","url":null,"abstract":"Objective: To describe the scientific production, through bibliometric analysis, about asthma in Latin America.Methods: Observational, descriptive, retrospective and cross-sectional study, with a quantitative bibliometric approach, to evaluate the scientific production of asthma in Latin America, using the Scopus and SciELO platforms to recover files published between 2003 and 2022.Results: A totoal of 3041 documents were obtained in Scopus and 592 in SciELO. In both repositories, the original articles (2379 and 478) and the reviews (379 and 43) were the most published documents. The larg-est producer was Brasil: n = 1538 in Scopus, and n = 406 in SciELO, and the journal with the highest number of publications was Jornal Brasileiro de Pneumologia with 169 articles in Scopus and 164 articles in SciELO.Conclusions: The bibliometric analysis shows the panorama of the last 20 years in research on asthma in Latin America, where scientific production has progressively increased, mainly in Brazil, Mexico and Chile.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 3","pages":"146-154"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Allergic bronchopulmonary aspergillosis in a patient with diabetes mellitus as the only risk factor].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-09-30 DOI: 10.29262/ram.v71i3.1383

Alejandro Hernández-Solís, Guillermo Velázquez-Sámano, Verónica Apolinar-Juárez, Eliasib Mojica Jaimes, Fryda Jareth Serna Valle, Yutzil Merari Velazquez Gachuz

{"title":"[Allergic bronchopulmonary aspergillosis in a patient with diabetes mellitus as the only risk factor].","authors":"Alejandro Hernández-Solís, Guillermo Velázquez-Sámano, Verónica Apolinar-Juárez, Eliasib Mojica Jaimes, Fryda Jareth Serna Valle, Yutzil Merari Velazquez Gachuz","doi":"10.29262/ram.v71i3.1383","DOIUrl":"https://doi.org/10.29262/ram.v71i3.1383","url":null,"abstract":"Background: Allergic bronchopulmonary aspergillosis is a rare entity, caused by a hypersensitivity reaction of the immune system to Aspergillus fumigatus, characterized by the presence of pulmonary infiltrates, bronchiectasis and increased eosinophils in peripheral blood.Case report: 42-year-old male with diabetes mellitus, with poor adherence to treatment, went to the emergency room due to rapidly progressive dyspnea and severe hypoxemia, pneumonia and bilateral pleural effusion were evident, laboratory studies reported, HbA1c 9.4%, eosinophils 3650 cells/mL, serum IgE for Aspergillus fumigatus 0.84 IU/mL. Treatment was started with supplemental oxygen, prednisone and itraconazole, to which the patient showed clinical and radiological improvement.Conclusions: Invasive mycoses have a mortality of 21 to 80%, frequently in immunocompromised patients, they are usually not described in patients with diabetes mellitus; The prevalence of fungal colonization among diabetic patients has been described as 37% compared to 4.7% in non-diabetic patients.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 3","pages":"212-215"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Necrotizing pneumonia in a patient with selective IgA deficiency].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-09-30 DOI: 10.29262/ram.v71i3.1344

María Enriqueta Núnez-Núñez, Denisse Monraz-Monteón, Juan Carlos Lona-Reyes, Luis Iván Pozos-Ochoa, Diego Magallón-Picazo, Beatriz Bayardo-Gutierrez

{"title":"[Necrotizing pneumonia in a patient with selective IgA deficiency].","authors":"María Enriqueta Núnez-Núñez, Denisse Monraz-Monteón, Juan Carlos Lona-Reyes, Luis Iván Pozos-Ochoa, Diego Magallón-Picazo, Beatriz Bayardo-Gutierrez","doi":"10.29262/ram.v71i3.1344","DOIUrl":"https://doi.org/10.29262/ram.v71i3.1344","url":null,"abstract":"Background: Inborn errors of immunity originate from monogenic mutations that should be considered in the suggestive diagnosis of patients with recurrent or severe infections, allergies, autoimmunity, autoinflammatory diseases, bone marrow failure and malignancy.Case report: Pediatric patient, male, 4 years old, treated in the medical service for fever of 39°C, difficult to control. The simple chest x-ray reported left pulmonary consolidation. The infectious condition evolved into necrotizing pneumonia of the left upper lobe, so it was decided to perform a lobectomy. The diagnosis of some inborn error of immunity was suspected. The determination of serum immunoglobulins reported IgA below the reference values. At 4 years he continued to have decreased serum IgA (5.5 mg/dL).Conclusions: The diagnosis of selective IgA deficiency is established after 4 years of life; However, due to the patient's severe infection, addressing some inborn error of immunity had to be implemented.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 3","pages":"205-211"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Adverse events from the Pfizer-BioNTech® COVID-19vaccine in children 5-17 years old].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-09-30 DOI: 10.29262/ram.v71i3.1387

María Del Rocío Hernández Morales, Margarita Aguirre Barbosa, Eleazar Mancilla Hernández, Sandra Aidée González Hidalgo, Estefanía Alavez López, Sandra Maldonado Castañeda

{"title":"[Adverse events from the Pfizer-BioNTech® COVID-19vaccine in children 5-17 years old].","authors":"María Del Rocío Hernández Morales, Margarita Aguirre Barbosa, Eleazar Mancilla Hernández, Sandra Aidée González Hidalgo, Estefanía Alavez López, Sandra Maldonado Castañeda","doi":"10.29262/ram.v71i3.1387","DOIUrl":"10.29262/ram.v71i3.1387","url":null,"abstract":"Objetives: To describe the events supposedly attributable to immunization with the Pfizer-BioNTech® COVID-19 vaccine in children aged 5 to 17 years in the state of Puebla, Mexico.Methods: Observational, cross-sectional and descriptive study carried out based on the analysis of reports of events supposedly attributable to immunization in children aged 5 to 17 years, who received the vaccine with the BNT162b2 mRNA platform for COVID-19, since January. to December 2022. Percentages, frequencies, averages, standard deviations and medians were used for statistical analysis. The Statistical Package for the Social Sciences 23 program was implemented.Results: 1,993,373 doses of the BNT162b2 vaccine were administered. 52 events presumed to be attributable to vaccination or immunization were reported. An annual rate of 2.6 per 100,000 doses applied was estimated. The age distribution recorded a median of 10.50 years (SD: 3.53). There were 56% women and 44% men; The most frequent symptoms were: dizziness, nausea, vomiting and pain at the vaccine application site. 2 cases of seizures and 1 of flaccid paralysis were reported.Conclusions: The safety of vaccines against SARS-CoV-2 requires an improvement in strategies for epidemiological surveillance (passive and active), with a more robust approach to guarantee safe vaccination.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 3","pages":"139-145"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Delayed hypersensitivity reactions to drugs: Group Report of the Drug Allergy Committee of the Mexican College of Clinical Immunology and Allergy (CMICA).]

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-09-30 DOI: 10.29262/ram.v71i3.1299

Rosalaura Virginia Villarreal-González, Margarita Ortega-Cisneros, Diana Estefanía Cadenas-García, Alejandra Canel-Paredes, Alira Fraga-Olvera, Angélica Delgado-Bañuelos, Germán Agustín Rico-Solís, Itzel Vianey Ochoa-García, Jaime Omar Jiménez-Sandoval, Jennifer Ramírez-Heredia, José Valentín Flores-González, Rosa María Cortés-Grimaldo, Yahvéh Zecua-Nájera

{"title":"[Delayed hypersensitivity reactions to drugs: Group Report of the Drug Allergy Committee of the Mexican College of Clinical Immunology and Allergy (CMICA).]","authors":"Rosalaura Virginia Villarreal-González, Margarita Ortega-Cisneros, Diana Estefanía Cadenas-García, Alejandra Canel-Paredes, Alira Fraga-Olvera, Angélica Delgado-Bañuelos, Germán Agustín Rico-Solís, Itzel Vianey Ochoa-García, Jaime Omar Jiménez-Sandoval, Jennifer Ramírez-Heredia, José Valentín Flores-González, Rosa María Cortés-Grimaldo, Yahvéh Zecua-Nájera","doi":"10.29262/ram.v71i3.1299","DOIUrl":"10.29262/ram.v71i3.1299","url":null,"abstract":"Background: Adverse drug reactions are defined as unexpected reactions, either derived from the pharmacokinetics of the treatment (Type A) or as a host immune response (Type B), resulting in harmful or undesirable manifestations in the patient following the administration of pharmacological therapy. Type B reactions are less defined and are considered a result of hypersensitivity to pharmacological treatment, categorized as immediate (within 1 to 6 hours after exposure) and delayed or non-immediate (occurring 6 hours after exposure).Objective: A review to describe the immunological mechanisms of delayed hypersensitivity reactions to drugs.Methods: A search of major medical databases on delayed hypersensitivity reactions to drugs was conducted. The review was limited to articles published in the period between 2013 and 2023, taking into consideration articles written in English and Spanish.Results: The terms defining delayed hypersensitivity reactions to drugs, their classification, clinical manifestations, diagnosis, treatment algorithms, and prognosis.Conclusions: Adverse drug reactions represent a challenge for the specialist physician, with a complex pathophysiology. A prompt diagnosis and treatment focused on the drug phenotype and its immunological expression are required to provide a multidisciplinary approach.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 3","pages":"169-188"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Acute urticaria].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-09-30 DOI: 10.29262/ram.v71i3.1364

Víctor Fernando Muñoz-Estrada, Edwin Daniel Maldonado-Domínguez

{"title":"[Acute urticaria].","authors":"Víctor Fernando Muñoz-Estrada, Edwin Daniel Maldonado-Domínguez","doi":"10.29262/ram.v71i3.1364","DOIUrl":"https://doi.org/10.29262/ram.v71i3.1364","url":null,"abstract":"Background: Urticaria is characterized by the transient appearance of hives, angioedema, or both. Acute urticaria lasts less than 6 weeks. The origin is idiopathic in more than 50% of cases, and the most frequent triggers are infectious processes, drugs and foods.Objective: Describe the origin, pathophysiology and treatment of patients with acute urticaria.Methods: A bibliographic search of articles was carried out in PubMed, where the Mesh terms: \"Urticaria\", \"Angioedema\" and \"Antihistamines\" were included and those with information related to acute urticaria were chosen, among those published from 2014 to 2023. In addition, the inclusion of some publications from previous years was considered, due to their relevance for this review.Results: The initial search returned 135 articles, but only 104 were used for the final manuscript.Conclusions: Acute urticaria is one of the most frequent reasons for consultation in the Allergology and Dermatology emergency services. Although there are multiple etiological factors, most cases are idiopathic, so it should not be overdiagnosed as an allergic reaction.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 3","pages":"189-204"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Dupilumab and atopic march; Reduction of incident allergic events or Clinical control?

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-09-30 DOI: 10.29262/ram.v71i3.1302

Jorge Sánchez, Leidy Alvarez, Susana Diez

引用次数: 0

[Allergic contact dermatitis due to Furacin®]. [Furacin®引起的过敏性接触性皮炎]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-06-30 DOI: 10.29262/ram.v71i2.1246

Lucía Moreno-Lozano, Teresa de Aramburu-Mera, Carmen Bermúdez-Hormigo

引用次数: 0

[Prevalence of dermatological manifestations in common variable immunodeficiency patients]. [常见变异性免疫缺陷病患者的皮肤病表现]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-06-30 DOI: 10.29262/ram.v71i2.1296

Brenda Guendulain-Velázquez, Patricia María O'Farrill-Romanillos

{"title":"[Prevalence of dermatological manifestations in common variable immunodeficiency patients].","authors":"Brenda Guendulain-Velázquez, Patricia María O'Farrill-Romanillos","doi":"10.29262/ram.v71i2.1296","DOIUrl":"https://doi.org/10.29262/ram.v71i2.1296","url":null,"abstract":"Objective: Estimate the prevalence of dermatological manifestations in Mexican patients with common variable immunodeficiency.Methods: Cross-sectional and retrospective study, based on the analysis of records of patients with a diagnosis of common variable immunodeficiency, treated at the Siglo XXI National Medical Center (Mexican Social Security Institute), according to the criteria of the European Society of Immunodeficiencies (ESID). and of which only 3 had a genetic diagnosis with the following mutations: IRF2, CTLA4 and PIK-3, belonging to the Immunodeficiency Clinic of the National Medical Center Siglo XXI (IMSS), to evaluate dermatological manifestations, review of laboratory tests: IgA, IgM, IgG and type of replacement therapy with Immunoglobulin. The statistical analysis was carried out with the SPSS program; Descriptive statistics were used to analyze the data, according to the type of variable to be analyzed.Results: 36 patients were included, of which 55.5% were women; with median age 34 years (18-94). The prevalence of dermatological manifestations was 70% (n = 25). 30.5% had a history of infectious dermatosis and 39.5% had a history of non-infectious dermatosis. The most common dermatosis was irritant contact dermatitis in 13.8% of patients. All received replacement therapy with human immunoglobulin, 33.3% intravenously and the rest subcutaneously.Conclusions: Common variable immunodeficiency is an inborn error of immunity, with different clinical manifestations in various organs and systems (the skin is one of these). Dermatological manifestations are not usually described in patients with common variable immunodeficiency; However, it is important to identify them due to their relationship with certain complications (increased risk of superinfection), due to skin disruption and biological therapies.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 2","pages":"91-95"},"PeriodicalIF":0.0,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Therapeutic effect of vitamin D supplementation in mexican patients with allergic rhinitis]. [补充维生素 D 对墨西哥过敏性鼻炎患者的治疗效果]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2024-06-30 DOI: 10.29262/ram.v71i2.1282

Daniela Rivero-Yeverino, Jonathan Higgins Payan-Diaz, Aída Inés López-García, José Sergio Papaqui-Tapia, Chrystopherson Gengyny Caballero-López, Juan Jesús Ríos-López, Carlos David López-Romero, Johav Yael Sánchez-Villalobos, Elisa Ortega Jordá-Rodríguez, Armando Álvarez-Rivera, Erika Villada-Villada

{"title":"[Therapeutic effect of vitamin D supplementation in mexican patients with allergic rhinitis].","authors":"Daniela Rivero-Yeverino, Jonathan Higgins Payan-Diaz, Aída Inés López-García, José Sergio Papaqui-Tapia, Chrystopherson Gengyny Caballero-López, Juan Jesús Ríos-López, Carlos David López-Romero, Johav Yael Sánchez-Villalobos, Elisa Ortega Jordá-Rodríguez, Armando Álvarez-Rivera, Erika Villada-Villada","doi":"10.29262/ram.v71i2.1282","DOIUrl":"10.29262/ram.v71i2.1282","url":null,"abstract":"Objetives: To evaluate the impact of cholecalciferol (D₃) supplementation using clinical and paraclinical variables in patients with RA and vitamin D insufficiency and deficiency.Methods: A randomized, double-blind, placebo-controlled study included patients from 5 to 40 years with a diagnosis of RA and vitamin D insufficiency and deficiency. They were supplemented for 8 weeks with 4000 or 5000 IU, depending on age. Total nasal symptoms score (TNSS) was measured monthly and 25(OH)D₃ levels at baseline and at the end of the study.Results: A total of 31 patients were included, with a mean age of 18.19 years. In the active group, there was a significant improvement in symptomatology with respect to the TNSS score and an increase in serum vitamin D levels (p < 0.01). There were no adverse reactions with cholecalciferol or placebo.Conclusions: Supplementing patients with vitamin D₃, at the evaluated dose, together with conventional treatent for allergic rhinitis results in symptoms and quality of life improvement in patients with this disease.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 2","pages":"85-90"},"PeriodicalIF":0.0,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0